Home › Funds › BOSTON RESEARCH & MANAGEMENT INC › CL
BOSTON RESEARCH & MANAGEMENT INC position in CL
COLGATE PALMOLIVE CO · Consumer Discretionary
BOSTON RESEARCH & MANAGEMENT INC reported holding 60,338 shares of CL (COLGATE PALMOLIVE CO) in its Q3 2026 13F filing — a position valued at US$5.1M, representing 1.14% of its reported portfolio and ranking #38 among its reported holdings. BOSTON RESEARCH & MANAGEMENT INC has disclosed CL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How BOSTON RESEARCH & MANAGEMENT INC's CL position evolved
BOSTON RESEARCH & MANAGEMENT INC first disclosed a stake in CL in Q3 2023 at 61,931 shares (US$4.4M). The position peaked in Q3 2024 at 64,051 shares, worth US$6.6M. Across 13 filings, BOSTON RESEARCH & MANAGEMENT INC increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 60,338 shares valued at US$5.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 61.93K | $4.40M | New |
| Q4 2023 | 64.01K | $5.10M | Add |
| Q1 2024 | 63.70K | $5.74M | Hold |
| Q2 2024 | 62.93K | $6.11M | Reduce |
| Q3 2024 | 64.05K | $6.65M | Add |
| Q4 2024 | 64.59K | $5.87M | Add |
| Q1 2025 | 63.80K | $5.98M | Reduce |
| Q2 2025 | 63.25K | $5.75M | Reduce |
| Q3 2025 | 63.93K | $5.11M | Add |
| Q4 2025 | 60.07K | $4.75M | Reduce |
| Q1 2026 | 60.67K | $5.17M | Add |
| Q2 2026 | 60.46K | $5.54M | Hold |
| Q3 2026 | 60.34K | $5.15M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CL and 13F data
CL (COLGATE PALMOLIVE CO) is a Consumer Discretionary company. 19 other funds we track also report a position in CL — the largest reported positions include First Eagle Investment Management (US$700.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CL
- First Eagle Investment Management 8.21M sh · $700.18M · Q3 2026
More on BOSTON RESEARCH & MANAGEMENT INC
FAQ
How long has BOSTON RESEARCH & MANAGEMENT INC held CL?
BOSTON RESEARCH & MANAGEMENT INC has disclosed CL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is BOSTON RESEARCH & MANAGEMENT INC's current position in CL?
As of Q3 2026, BOSTON RESEARCH & MANAGEMENT INC holds 60.34K shares of CL (COLGATE PALMOLIVE CO), valued at $5.15M, representing 1.14% of its reported portfolio and ranking #38.
Has BOSTON RESEARCH & MANAGEMENT INC been buying or selling CL?
In the latest 13F filing (Q3 2026), BOSTON RESEARCH & MANAGEMENT INC held unchanged its position in CL. The position peaked in Q3 2024 at 64.05K shares.
Which other funds hold CL?
Other major institutional holders of CL include First Eagle Investment Management, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.